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Outcomes and care practices for preterm
infants born at less than 33 weeks’ gestation:
a quality-improvement study
Shoo K. Lee MBBS PhD, Marc Beltempo MD, Douglas D. McMillan MD, Mary Seshia MBChB, Nalini Singhal MD,
Kimberly Dow MD, Khalid Aziz MBBS MEd, Bruno Piedboeuf MD, Prakesh S. Shah MD; on behalf of the
Evidence-based Practice for Improving Quality Investigators*
n Cite as: CMAJ 2020 January 27;192:E81-91. doi: 10.1503/cmaj.190940
*The full list of Evidence-based Practice for Improving Quality Investigators can be found at the end of the article.
See related article at www.cmaj.ca/lookup/doi/10.1503/cmaj.200008

ABSTRACT
BACKGROUND: Preterm birth is the leading cause of morbidity and mortality in
children younger than 5 years. We
report the changes in neonatal outcomes and care practices among very
preterm infants in Canada over 14 years
within a national, collaborative, continu
ous quality-improvement program.

out major morbidity during the initial
hospital admission. We quantified
changes using process-control charts in
6-month intervals to identify specialcause variations, adjusted regression
models for yearly changes, and interrupted time series analyses.

METHODS: We retrospectively studied

included 50 831 infants. As a result of
practice changes, survival without
major morbidity increased significantly
(56.6% [669/1183] to 70.9% [1424/2009];
adjusted odds ratio [OR] 1.08, 95% confidence interval [CI] 1.06–1.10, per year)
across all gestational ages. Survival of
infants born at 23–25 weeks’ gestation

infants born at 23–32 weeks’ gestation
who were admitted to tertiary neonatal
intensive care units that participated in
the Evidence-based Practice for Improving Quality program in the Canadian
Neonatal Network from 2004 to 2017.
The primary outcome was survival with-

P

RESULTS: The final study population

reterm birth is rising rapidly around the world (incidence
ranges from 5% to 18%) and is the leading cause of cerebral palsy, autism, developmental delay and death
among children younger than 5 years.1,2 Among preterm infants,
those born before 33 weeks’ gestation are at highest risk of mortality and morbidity, with resultant financial and social costs for
families and society.3,4 The Canadian Neonatal Network was
established in 1995 to benchmark and improve national neonatal
outcomes in the setting of a health system in which hospital care
and physicians are publicly funded.
The Canadian Neonatal Network includes all tertiary level
neonatal intensive care units (NICUs) across Canada, whose

© 2020 Joule Inc. or its licensors

increased (70.8% [97/137] to 74.5%
[219/294]; adjusted OR 1.03, 95% CI
1.02–1.05, per year). Changes in care
practices included increased use of antenatal stero ids (83.6% [904/1081] to
88.1% [1747/1983]), increased rates of
normothermia at admission (44.8%
[520/1160] to 67.5% [1316/1951]) and
reduced use of pulmonary surfactant
(52.8% [625/1183] to 42.7% [857/2009]).
INTERPRETATION: Network-wide qualityimprovement activities that include better implementation of optimal care
practices can yield sustained improvement in survival without morbidity in
very preterm infants.

population of 36 million with 360 000 annual births is served by
regionalized perinatal care systems of maternity units and 31 tertiary level NICUs. In 2003, we launched a national Evidencebased Practice for Improving Quality (EPIQ) program within the
Canadian Neonatal Network. This program is unique because it is
national in scale, shows how self-learning systems can work and
has been sustained over time.
In this study, we report the impact of the EPIQ program
on outcomes of very preterm infants born at 23–32 weeks’
gestation in Canada from 2004 to 2017, in line with the Standards for Quality Improvement Reporting Excellence 2.0
guidelines. 5
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Methods
The EPIQ program is a collaborative, multifaceted qualityimprovement approach that combines iterative learning techniques using Plan-Do-Study-Act cycles of rapid change with a process to facilitate quality improvement through benchmarking,
best-practice consensus, engagement of front-line staff and
mutual learning via networking. In addition, we used institutionspecific data to target practices with high attributable risk of
adverse outcomes for interventions and to minimize use of inefficient “shotgun” approaches for quality improvement. The program emphasizes changing individual behaviour and organizational culture.6 We established a central resource for knowledge
and data management, assessed organizational culture and
behaviour, created multidisciplinary teams that included parents
and staff, and used a train-the-trainer approach to engage staff
and implement Plan-Do-Study-Act cycles at participating NICUs.

Study population

pediatric estimate. We used Canadian standards to classify
infants as small for gestational age (< 10th percentile).10 We
collected data on specific care practices, including delivery in
a tertiary care unit (inborn), use of antenatal steroids (partial
or complete), normothermia on admission (between 36.5°C
and 37.5°C), use of pulmonary surfactant, cesarean birth and
use of systemic postnatal steroids.

Key practice changes
Our group has previously described specific changes in practice,
process measures and results of each epoch.11–14 Key timelines and
the 5 most common practice changes are reported in Figure 1. In
Epoch 1, they included interventions targeted to reduce bronchopulmonary dysplasia and nosocomial infection, whereas in
Epochs 2 and 3, the interventions targeted all major morbidity
outcomes described below.

Outcomes

We conducted a retrospective cohort study involving infants
born from 23+0 to 32+6 weeks’ gestation and admitted to participating NICUs between Jan. 1, 2004, and Dec. 31, 2017. Canada’s
NICUs range in size from 20 to 83 (median 30) beds, and care for
102 to 1200 admissions per year and 0 to 7000 births annually.7
Twenty-two NICUs collected data from 2004 and another 7 commenced in 2008.
Over the 14-year study period, there were 3 main epochs of
the EPIQ program. All units that were part of the Canadian Neonatal Network were offered the opportunity to participate in the
program. Twelve (out of 17) tertiary level NICUs voluntarily participated in Epoch 1 (2004–2008), and 25 (out of 29) participated
in Epochs 2 (2009–2012) and 3 (2013–2017). We included all eligible infants admitted to each participating site. We excluded
infants who were moribund on admission, had major congenital
anomalies, were missing gestational age or birth weight, or were
admitted more than 7 days after birth. Our cohort included more
than 80% of eligible infants born in Canada as some low-risk
infants were cared for in non-ICUs that did not participate in the
EPIQ program.

For this analysis, the primary outcome was survival to NICU
discharge without major morbidities, selected based on frequency and potential for long-term neurodevelopmental
impact. Major morbidity was defined as 1 or more of late-onset
sepsis, necrotizing enterocolitis, bronchopulmonary dysplasia,
severe retinopathy of prematurity, or severe neurologic injury.
We defined bronchopulmonary dysplasia as need for supplemental oxygen at 36 weeks’ postmenstrual age, or time of discharge or transfer.15 We defined severe neurologic injury as
grade III or IV intraventricular hemorrhage according to Papile
and colleagues16 or periventricular echogenicity. We defined
retinopathy of prematurity as stage III or greater in at least
1 eye according to the international classification,17 or need for
treatment. We defined necrotizing enterocolitis as stage 2 or
greater diagnosed according to Bell’s criteria.18 We defined
late-onset sepsis as positive blood or cerebrospinal fluid culture in a symptomatic neonate after 2 days of age. Secondary
outcomes included individual components of the primary outcome and early-onset sepsis, defined as positive blood or cerebrospinal fluid culture in a symptomatic neonate in the first
2 days after birth.

Data collection

Statistical analysis

The Canadian Neonatal Network provides standardized training
for all dedicated data abstractors in the respective institutions.
A standard data dictionary and data-collection protocol is followed by all abstractors.8 Anonymized patient data are entered
electronically into a purpose-built program, with error checks
at entry. The Canadian Neonatal Network database has shown
high reliability and internal consistency.9 The first (S.K.L.) and
last (P.S.S.) authors had full access to all data and analyses. A
statistician (X.Y.Y.) at the Maternal–Infant Care Research Centre, Sinai Health System, conducted the data analysis.

We used 3 statistical methods: process-control charts evaluating common and special-cause variations, trend analyses and
interrupted time series analyses. We used process-control
methods to describe, detect and understand changes in processes of care and outcomes. We plotted crude rates using
6-month periods to provide sufficient time points for processcontrol chart analysis while maintaining more than 100 observations for subgroups. 19 For each graph, upper and lower
control limits were determined using standard statistical
process-control parameters (± 3 standard deviations) using the
14-year data. We had not preplanned to revise or “lock” the limits of the process-control charts because no data were available
to establish baseline rates, and we aimed to have 24 data
points. We identified special-cause variation in outcomes (significant changes that are not part of random variation) as any

Variable definitions
We calculated gestational age hierarchically from best estimate based on the date of in vitro fertilization, early prenatal
ultrasonography, last menstrual period, obstetric estimate and
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2004

EPIQ-I (2004–2006): targeting single outcomes

2005

Strategic placement of cleanser dispensers in NICUs
Use of 2% aqueous chlorhexidine for skin antisepsis
Restrict number of skin breaks per patient
For rule out of sepsis, discontinue antibiotics if 36–48-hour
cultures are negative

2006
2007

Bronchopulmonary dysplasia
• Prophylactic surfactant for infants born < 28 weeks
• Restrict hand ventilation
• Adopt normocarbia policy (keep PCO2 between 40 and 55 mm Hg)
• Target oxygen saturation between 88% and 92%
• Early parenteral protein and lipid nutrition < 4 hours after birth

EPIQ-PHSI (2006–2008) : generalizability and national application
• QI training and dissemination of practice change guidelines
to non-EPIQ NICUs

• Evaluating the improvements in NICUs that did not participate
in EPIQ-1 trial

2008
2009

2010

EPIQ-II (2009–2012): targeting mortality and 5 major morbidities simultaneously

Nosocomial infection

Bronchopulmonary dysplasia

Severe neurologic injury

Necrotizing enterocolitis

• Central line management,
bundle
• Hand hygiene
• Central line management,
single intervention
• Education, audit, teambuilding
• Reduce skin breaks
• Skin-to-skin care
• Checklist for central lines

• Use of T-piece resuscitator
• Enhancing or ensuring early
use of continuous positive
airway pressure
• Controlled oxygen use or
review of oxygen saturation
• Early use of surfactant
and/or early extubation
• Ventilator weaning algorithm
• Prophylactic surfactant

• Delayed cord clamping
• Use of antenatal magnesium
sulphate
• Minimal use of volume expanders
• Minimum use of inotropes

•
•
•
•

2011

2012

2013

2014

Retinopathy of prematurity
• Controlled oxygen use
• Improved screening protocol

Feeding guidelines
Early feeding
Use of donor milk
Colostrum or enhanced
expressed breast milk
• Early total parental
nutrition
• Hold enteral feeds during
erythrocyte transfusion

EPIQ-II (2011–present): neurodevelopmental follow-up
• Collection of outcome data at 18 months corrected age and 36 months chronological age

EPIQ-III (2013–2017): targeting specific patient groups and processes of care
• Continuous quality improvement;
review of bundles to focus efforts;
implement practice updates

• Implementation of sentinel event reviews
• Detailed site visits

• Driving force to reach an incidence of
near zero in 5 major morbidities over
a 3-year intervention period

2015

2016

2017
Figure 1: Timeline of key practice changes (during Epoch 1 [2004–2008], Epoch 2 [2009–2012] and Epoch 3 [2013–2017]) implemented by participating hospitals using the EPIQ method. The 5 most commonly implemented interventions were central venous catheter management bundles in different forms, development and implementation of guidelines for respiratory management of a neonate who is receiving invasive or noninvasive
respiratory support, development and implementation of feeding guidelines, controlled use of oxygen, and neurologic injury prevention bundle.
Note: EPIQ = Evidence-based Practice for Improving Quality, NICU = neonatal intensive care unit, PHSI = Partnerships for Health Systems Improvement, QI = quality improvement.

data point beyond the control limits, or 8 sequential points on
1 side of the mean, in either direction.20,21
We evaluated linear trends for changes in patient characteristics, care practices and outcomes using F or Wald χ2 tests from lin-

ear or logistic regression models with the 1-year periods used as a
continuous variable. We adjusted models, using a generalized
estimating equation approach (to account for clustering within
site) with symmetric covariance structure, for the most common
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Nosocomial infection
•
•
•
•
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variables known to be associated with the outcomes: gestational age in weeks (as a categorical variable), sex, multiple
births, small for gestational age, outborn status, Score for Neonatal Acute Physiology version II greater than 20,22 and ante
natal steroids. We conducted trend analysis based on infants
with nonmissing values of covariates and outcomes. We did not
impute data, as more than 96% of infants had complete data.23
We also analyzed trends in the primary outcome using interrupted time series models to determine whether there were different effects in the 3 epochs. We used generalized estimated
equations to examine linear trends in 3-month periods (to allow
sufficient time points).24 We analyzed the change in trends for
the 3 epochs.
We conducted sensitivity analyses for survival and survival
without major morbidity for the 22 hospitals that participated
throughout the 14-year period to evaluate the potential effect of
changes in participating hospitals over time.

We carried out data management and statistical analyses
using SAS version 9.3 and R version 3.2.2. We regarded a 2-sided
p value of less than 0.05 as statistically significant.

Ethics approval
We obtained waivers of individual informed consent from institutional ethics or quality-improvement committees from all participating hospitals.

Results
Of the 54 923 infants born between 23 and 32 weeks’ gestation and
admitted to participating NICUs during the study period, 4092 infants (7.5%) were excluded; 532 (1.0%) were moribund on admission, 1936 (3.5%) had major congenital anomalies, 62 (0.1%) had
missing gestational age or birth weight, and 1562 (2.8%) were admitted more than 7 days after birth (Appendix 1, eFigure 1, available

Table 1: Maternal and infant characteristics of very preterm infants admitted to neonatal intensive care units in Canada,
2004–2017
No. (%) of infants*
Characteristic

Epoch 1 (2004–2008)
n = 15 060*

Epoch 2 (2009–2012)
n = 15 692*

Epoch 3 (2013–2017)
n = 20 079*

p value
for epochs†

p value
for linear
trend‡

Maternal
Age, yr, mean ± SD

30.2 ± 6.0

30.7 ± 5.9

31.3 ± 5.8

< 0.001

< 0.001

Hypertension

n = 14 750
2676 (18.1)

n = 15 200
2912 (19.2)

n = 19 524
3681 (18.9)

0.07

0.1

Prenatal care

n = 14 440
14 080 (97.5)

n = 14 577
14 314 (98.2)

n = 19 307
18 702 (96.9)

< 0.001

< 0.001

n = 13 678
1764 (12.9)

n = 12 183
2115 (17.4)

n = 14 758
3081 (20.9)

< 0.001

< 0.001

29 (27–31)

30 (27–31)

30 (27–31)

0.9

> 0.9

Chorioamnionitis
Infant
Gestational age, wk, median (IQR)
Gestational age group, wk

< 0.001

23–25

1729 (11.5)

1906 (12.1)

2630 (13.1)

26–28

4101 (27.2)

4014 (25.6)

5042 (25.1)

29–32

9230 (61.3)

9772 (62.3)

12 407 (61.8)

Birth weight, g, mean ± SD

1324 ± 451

1328 ± 454

1325 ± 454

0.7

0.8

Sex, male

n = 15 036
8031 (53.4)

n = 15 671
8645 (55.2)

n = 20 054
10 989 (54.8)

0.005

0.02

Singleton

n = 15 008
10 338 (68.9)

n = 15 683
10 679 (68.1)

14 038 (69.9)

0.001

0.02

Small for gestational age

n = 15 037
1429 (9.5)

n = 15 680
1530 (9.8)

n = 20 059
1971 (9.8)

0.6

0.3

Minor congenital malformation

2423 (16.1)

2472 (15.8)

3249 (16.2)

0.5

0.8

SNAP-II score > 20

n = 15 051
2690 (17.9)

n = 15 546
2527 (16.3)

n = 19 900
2954 (14.8)

< 0.001

< 0.001

Note: IQR = interquartile range, SD = standard deviation, SNAP = Score for Neonatal Acute Physiology.
*Unless stated otherwise.
†The p value for differences between the 3 epochs were obtained using the χ2 test for categorical variables and F test or Kruskal–Wallis test as appropriate.
‡The p value for linear trend was for 2004–2017. Significance was assessed using the F or Wald χ2 test from linear or logistic regression models using 1-year periods as an independent
continuous variable.
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Survival by gestational age group

Survival without major morbidity

Trend analysis showed special-cause variations (decreases) in
bronchopulmonary dysplasia, retinopathy of prematurity and
late-onset sepsis (Figure 4) (Appendix 1, eTable 1). There was
special-cause variation (decrease) and a significant decreasing
trend in the rate of the composite outcome of death or bronchopulmonary dysplasia (adjusted OR for yearly change, 0.94, 95% CI
0.92–0.97) (Appendix 1, eFigure 4).
There were no special-cause variations in severe neurologic
injury, necrotizing enterocolitis and early-onset sepsis (Figure 4). However, trend analysis showed a significant reduction
in the rate of necrotizing enterocolitis (Appendix 1, eTable 2).
Yearly trend analysis stratified by gestational age strata indicated that necrotizing enterocolitis was significantly reduced
among infants born at 26 to 32 weeks’ gestation, and severe
neurologic injury was significantly reduced only among infants
born at 26 to 28 weeks’ gestation (Appendix 1, eTable 1).

Survival without major morbidity increased with increasing gestational age and for all gestational age groups over the entire
study period (Figure 2). Between 2004 (first 6 months) and 2017
(last 6 months), survival without major morbidity increased from
7.3% (10/137) to 12.9% (38/294) for infants born at 23–25 weeks’
gestation and from 32.0% (113/353) to 60.0% (282/470) for
infants born at 26–28 weeks’ gestation. Trend analysis confirmed
this improvement for every gestational age group and in every
epoch (Appendix 1, eTable 1).
For all infants, there was special-cause variation (increase) in
survival without major morbidity from 2004 (first 6 months) to
2017 (last 6 months) (Appendix 1, eFigure 2; 56.6% [669/1183] to
70.9% [1424/2009]). The annual trend in survival without major
morbidity increased significantly (adjusted odds ratio [OR] 1.08,
95% confidence interval [CI] 1.06–1.10) and the odds of survival
without major morbidity increased with each epoch (Appendix 1, eTable 2). Interrupted time series analyses showed that all
3 epochs were associated with improving outcomes (all slopes
> 0, p < 0.002). There was no significant difference in the slope of
change across the 3 epochs (Appendix 1, eFigure 3).

Survival also increased with increasing gestational age. There
was special-cause variation (increase) in survival among infants
born at 23–25 weeks’ gestational age (Figure 3), confirmed in
trend analysis (adjusted OR for yearly change in survival among
infants born at 23–25 weeks’ gestation, 1.03, 95% CI 1.02–1.05)
(Appendix 1, eTable 1), but not among infants born at more than
25 weeks’ gestation.

Neonatal morbidities

Care practices
There were special-cause variations (increase) in the proportions
of infants delivered at perinatal centres who were normothermic
on admission (44.8% [520/1160] to 67.5% [1316/1951]) and

Table 2: Outcomes of very preterm infants admitted to neonatal intensive care units in Canada, 2004–2017
No. (%) of infants
Epoch 1 (2004–2008)
n = 15 060*

Epoch 2 (2009–2012)
n = 15 692*

Epoch 3 (2013–2017)
n = 20 079*

p value
for epochs†

p value
for linear
trend‡

Survival without major
morbidity

9035 (60.0)

10 063 (64.1)

13 886 (69.2)

< 0.001

< 0.001

Bronchopulmonary dysplasia

n = 14 129
2937 (20.8)

n = 14 721
2665 (18.1)

n = 18 954
2862 (15.1)

< 0.001

< 0.001

Severe neurologic injury

n = 11 593
1531 (13.2)

n = 12 775
1559 (12.2)

n = 16 531
1804 (10.9)

< 0.001

< 0.001

Necrotizing enterocolitis

n = 14 920
716 (4.8)

n = 15 634
728 (4.7)

n = 20 067
805 (4.0)

0.001

< 0.001

Severe retinopathy of
prematurity

n = 6605
760 (11.5)

n = 6464
641 (9.9)

n = 8533
793 (9.3)

< 0.001

< 0.001

Early-onset sepsis

202 (1.3)

218 (1.4)

342 (1.7)

0.007

< 0.001

Late-onset sepsis

2616 (17.4)

2248 (14.3)

2212 (11.0)

< 0.001

< 0.001

14 027 (93.1)

14 629 (93.2)

18 866 (94.0)

0.002

0.001

Outcome

Survival

*Unless stated otherwise.
†The p value for differences between the 3 epochs were obtained using the χ2 test.
‡The p value for linear trend was for 2004–2017. Significance was assessed using the Wald χ2 test from logistic regression models using 1-year periods as an independent continuous
variable.
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at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.190940/-/DC1).
The proportions of excluded patients remained similar across study
years. The final study population included 50 831 infants. Maternal
and infant characteristics are presented in Table 1. During the study
period, maternal age and the rate of chorioamnionitis increased.
There was a small but significant increase in the proportion of male
and singleton infants and a decrease in infants with Score for Neonatal Acute Physiology version II greater than 20 (Table 1). Infant
outcomes are presented in Table 2.

RESEARCH

100

UL = 94%
31–32 wk, mean = 90%
LL = 86%

Outcome, %

80

UL = 85%
29–30 wk, mean = 76%
LL = 67%

60

UL = 53%
26–28 wk, mean = 45%
LL = 34%

40

UL = 20%
23–25 wk, mean = 11%
LL = 3%

20
0

2004

2006

2008

2010

2012

2014

2016

Admission period, yr

Figure 2: Survival to discharge without major morbidity. Process-control charts for survival to discharge without
major morbidity by gestational age group. Means (solid lines) and upper (UL) and lower (LL) control limits (dotted
and dashed lines) are calculated using 2004–2017 data. Margins of the limits were recalculated for each period based
on the number of infants per 6-month period, and the reported UL and LL correspond to the first 6 months of 2004.
Large dots show the percentage of infants admitted each 6-month period who survived without major morbidity. The
percentages are among all infants within the gestational age group. The total numbers of infants in each group are
6265 for 23–25 weeks, 13 157 for 26–28 weeks, 12 868 for 29–30 weeks and 18 541 for 31–32 weeks. The median (range)
numbers of infants for each 6-month period are 229 (137–294) for 23–25 weeks, 485 (353–532) for 26–28 weeks,
490 (253–550) for 29–30 weeks and 700 (440–820) for 31–32 weeks.

exposed to antenatal steroids (83.6% [904/1081] to 88.1%
[1747/1983]) (Figure 5). There were special-cause variations
(decreases) in pulmonary surfactant use (52.8% [625/1183] to
42.7% [857/2009]).

Sensitivity analysis
Sensitivity analyses using the survival and survival without
major morbidity results of 22 units that participated during
the entire study period were similar and are reported in
Appendix 1, eTable 3. Similar to findings in the main analysis,
the annual trend in survival without major morbidity among
infants born at 23–32 weeks’ gestation increased significantly
(adjusted OR 1.08, 95% CI 1.05–1.10) and the odds of survival
without major morbidity increased with each epoch. The
annual trend in survival increased significantly among infants
born at 23–25 weeks’ gestation (adjusted OR 1.03, 95% CI
1.01–1.05), but was not significant among infants born at
more than 25 weeks.

Interpretation
Participation in the EPIQ program was associated with a 25%
increase in survival without major morbidity among very preterm infants and a 5% increase in survival among infants born
at 23–25 weeks’ gestation. Participation in the program was
also associated with reductions in specific morbidities, including bronchopulmonary dysplasia, retinopathy of prematurity,
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late-onset sepsis and necrotizing enterocolitis. These improvements occurred concomitantly with improvements in care
practices including use of antenatal steroids, management of
hypothermia, and more targeted use of pulmonary surfactant.
Our results show that a self-learning, long-term strategy of
deliberate and measured process changes can yield sustained
benefits.
Quality improvement is a continually evolving process.
Each epoch in our study had a different focus, informed from
previous results. Epoch 1 (2003–2005) was a clusterrandomized trial that targeted single outcomes and showed
significant reductions in bronchopulmonary dysplasia (15%)
and late-onset sepsis (44%) compared with the control
group. 11 From 2005 to 2007, we disseminated practice
guidelines from Epoch 1 to other NICUs. We found continued
improvement among some NICUs that participated in the
Epoch 1 study, but not others. This was consistent with reports
that practice guidelines without active engagement have
limited impact.25,26
Epoch 2 (2008–2012) was a pre–post cohort study targeting
multiple outcomes (mortality and the 5 major morbidities)
simultaneously and emphasizing context and facilitation to
change individual behaviour and organizational culture.12 We
showed a significant increase in survival without major morbidity (adjusted OR 1.59, 95% CI 1.26–1.96) and reductions in
retinopathy (adjusted OR 0.60, 95% CI 0.45–0.79), necrotizing
enterocolitis (adjusted OR 0.73, 95% CI 0.52–0.98) and
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Figure 3: Survival to discharge. Process-control charts for overall survival to discharge by gestational age group. Means (solid lines) and upper (UL) and
lower (LL) control limits (dotted and dashed lines) are calculated using 2004–2017 data. Margins of the limits were recalculated for each period based
on the number of infants per 6-month period, and the reported UL and LL correspond to the first 6 months of 2004. Large dots show the percentage of
infants admitted each 6-month period who survived to discharge. The percentages are among all infants within the gestational age group. The total
numbers of infants in each group are 6265 for 23–25 weeks, 13 157 for 26–28 weeks, 12 868 for 29–30 weeks and 18 541 for 31–32 weeks. The median
(range) numbers of infants for each 6-month period are 229 (137–294) for 23–25 weeks, 485 (353–532) for 26–28 weeks, 490 (253–550) for 29–30 weeks
and 700 (440–820) for 31–32 weeks.

late-onset sepsis (adjusted OR 0.63, 95% CI 0.48 to 0.82).12
However, we also observed that infants benefited more if they
were born at 25 weeks’ gestation or less, and hypothesized
that targeting specific patient groups and processes of care
may yield benefits.
Epoch 3 (2013–2017) targeted specific patient groups and
processes of care, such as the first week after birth, avoiding
mechanical ventilation, enhancing feeding and nutrition,
supporting developmental care, and conducting routine
audits of sentinel events; and encouraged inter-NICU visits to
facilitate mutual learning. 14 We observed further improvements in survival without major morbidity (adjusted OR 1.38,
95% CI 1.19–1.63).

Our results from interrupted time series analyses showed that
all 3 epochs were associated with similar and continuous
improvements in outcomes. Consistent with our findings, a retrospective cohort study involving preterm neonates born at less
than 29 weeks’ gestation among 10 high-income countries participating in the International Network for Evaluation of Outcomes between 2007 and 2015 reported that neonatal outcomes
improved most in Canada, and Canada moved rank from last to
second best.27 Canada’s quality-improvement program was proposed as one reason for the improvement. Today, the EPIQ program is standard practice in Canadian NICUs, and the concept
has been embraced in other countries, including Australia, New
Zealand, Sweden, Japan, China, Malaysia and Latin America.28
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Figure 4: Process-control charts for neonatal morbidities among infants born at gestational age 23 through 32 weeks. Means (solid lines) and upper
(UL) and lower (LL) control limits (dotted and dashed lines) calculated using 2004–2017 data. Margins of the limits were recalculated for each period
based on the number of infants per 6-month period, and the reported UL and LL correspond to the first 6 months of 2004. Large dots show the percentage of infants admitted each 6-month period who developed the outcome. Percentage of bronchopulmonary dysplasia is among infants either alive at
36 weeks corrected, or at discharge or transfer if discharged before 36 weeks corrected (n = 47 804). Percentage of severe neurologic injury is among
infants with at least 1 documented head imaging examination (ultrasound, computed tomography or magnetic resonance imaging) (n = 40 899). Percentage of necrotizing enterocolitis is among all infants with available data (n = 50 621). Percentage of severe retinopathy of prematurity is among
infants who had a least 1 documented eye examination (n = 21 807). Percentage of early-onset sepsis is among all infants (n = 50 831). Percentage of
late-onset sepsis is among all infants (n = 50 831). The median number of infants for each 6-month period was 1937 (range 538–2153).
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Figure 5: Process-control charts for care practices for infants born at gestational age 23 through 32 weeks. Means (solid lines) and upper (UL) and
lower (LL) control limits (dotted and dashed lines) calculated using 2004–2017 data. Margins of the limits were recalculated for each period based
on the number of infants per 6-month period, and the reported UL and LL correspond to the first 6 months of 2004. Large dots show the percentage of infants admitted each 6-month period who received each care practice among all eligible infants. Denominators used to calculate percentages were all infants (n = 50 831). The median number of infants for each 6-month period was 1937 (range 1182–2152). Note: NICU = neonatal
intensive care unit.
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In 2017, we expanded the EPIQ program to high-risk maternity units so that quality of care could be improved upstream
and across the whole spectrum of perinatal care, from pregnancy
to childbirth and infancy. Indeed, our approach should be applicable to health care beyond the NICU.

Limitations
Our study had several limitations. First, since Epochs 2 and 3
were pre–post comparisons, outcome improvements are associations that are potentially affected by residual confounding
and do not confirm a causal relation between interventions
and outcomes. Second, we may have overestimated survival
because stillbirths, delivery room deaths and infants moribund
on admission were excluded from our analyses. However,
excluded neonates were not targeted by quality-improvement
interventions, and their proportions have not changed over
time. Third, since individual NICUs made different practice
interventions at different times, we cannot provide analyses of
specific interventions responsible for changes in outcomes.
Fourth, controlled interrupted time series analyses could provide change compared with a reference time point; however,
because of the continuous nature of our program, we used traditional measures to assess the impact of our interventions.
Last, the objective of the program was to improve short-term
hospital-based outcomes; long-term neurodevelopmental outcomes were not available for this cohort but are now being
tracked by the Canadian Neonatal Network and should be
available for future cohorts.

Conclusion
The EPIQ program in Canada has led to increases in survival and
decreases in morbidity among infants born preterm, alongside
the provision of improved care practices. The key lessons from
the program are that a scientifically rigorous self-learning system
is an effective and sustainable way to improve quality of care,
and patient outcomes can be improved by doing better with
what we already know and have.
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